Kevin Outterson, JD, LLM
Professor of Law and N. Neal Pike Scholar
Boston University School of Law
Dept of Health and Disability Law

LLM, University of Cambridge
JD, Northwestern University School of Law

Research interests in pharmaceutical innovation, including the law & economics of antimicrobial resistance.

Associate Professor of Health Law, Ethics & Human Rights
Boston University School of Public Health
Health Law, Policy & Management
Center for Health Law, Ethics & Human Rights

Executive Director of CARB-X
Boston University School of Law
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)

RESTRICTED: Accelerating the Development of Innovative Preventive Approaches to Combat AMR
01/01/2019 - 12/31/2022 (PI)
The German Federal Ministry of Education and Research

Accelerating the Development ofinnovative Preventive Approaches to Combat AMR
05/18/2018 - 05/31/2022 (PI)
Bill and Melinda Gates Foundation

05/18/2018 - 03/31/2022 (PI)
Department of Health and Social Care

Accelerating the Development of Innovative Preventive Approaches to Combat AMR
01/01/2019 - 12/31/2021 (PI)
The German Federal Ministry of Education and Research

WT CARB-X Core Mgmt/Other Program Support
01/01/2019 - 07/31/2021 (PI)
Wellcome Trust

WT CARB-X PD/Acc Costs Cost-Share
04/01/2017 - 07/31/2021 (PI)
Wellcome Trust

WT CARB-X Non Awardee Costs
04/01/2017 - 07/31/2021 (PI)
Wellcome Trust

08/01/2016 - 07/31/2021 (PI)
HHS/Assistant Secretary for Preparedness and Response
6 IDSEP160030-04-02


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Rex JH, Outterson K. Antibacterial R&D at a crossroads: We've pushed as hard as we can … now we need to start pulling! Clin Infect Dis. 2020 Jun 25. PMID: 32584949
  2. Outterson K, Rex JH. Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization. Transl Res. 2020 06; 220:182-190. PMID: 32165059
  3. Laxminarayan R, Van Boeckel T, Frost I, Kariuki S, Khan EA, Limmathurotsakul D, Larsson DGJ, Levy-Hara G, Mendelson M, Outterson K, Peacock SJ, Zhu YG. The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later. Lancet Infect Dis. 2020 04; 20(4):e51-e60. PMID: 32059790
  4. Boucher HW, File TM, Fowler VG, Jezek A, Rex JH, Outterson K. Antibiotic Development Incentives That Reflect Societal Value of Antibiotics. Clin Infect Dis. 2020 Jan 30. PMID: 31999818
  5. Årdal C, Balasegaram M, Laxminarayan R, McAdams D, Outterson K, Rex JH, Sumpradit N. Antibiotic development - economic, regulatory and societal challenges. Nat Rev Microbiol. 2020 05; 18(5):267-274. PMID: 31745330
  6. Theuretzbacher U, Outterson K, Engel A, Karlén A. The global preclinical antibacterial pipeline. Nat Rev Microbiol. 2020 05; 18(5):275-285. PMID: 31745331
  7. Van Katwyk SR, Balasegaram M, Boriello P, Farrar J, Giubilini A, Harrison M, Kieny MP, Kirchhelle C, Liu J, Outterson K, Pate MA, Poirier M, Røttingen JA, Savulescu J, Sugden R, Thamlikitkul V, Weldon I, Davies S, Hoffman SJ. A roadmap for sustainably governing the global antimicrobial commons. Lancet. 2019 11 16; 394(10211):1788-1789. PMID: 31741444
  8. Outterson K. A shot in the arm for new antibiotics. Nat Biotechnol. 2019 10; 37(10):1110-1112. PMID: 31578512
  9. Rex JH, Fernandez Lynch H, Cohen IG, Darrow JJ, Outterson K. Designing development programs for non-traditional antibacterial agents. Nat Commun. 2019 07 31; 10(1):3416. PMID: 31366924
  10. Barlam TF, Morgan JR, Kaplan WA, Outterson K, Pelton SI. Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship. J Pediatric Infect Dis Soc. 2019 Mar 28; 8(1):63-65.View Related Profiles. PMID: 28992176
Showing 10 of 75 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 75 publications over 19 distinct years, with a maximum of 9 publications in 2011

Contact for Mentoring:

765 Commonwealth Ave
Boston MA 02215
Google Map

Outterson's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People